Forth, we could not acquire the accurate information of prostate cancer screening program in individual country, including the population coverage, screening rates, form of implementation and health effectiveness, which may result in bias when inferring the effect of PSA screening on incidence and mortality of prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.